Discover high-conviction stock picks and new investing opportunities with the TipRanks Smart Investor Newsletter
GlaxoSmithKline (GB:GSK)
In a report released yesterday, Graham Parry from Citi maintained a Hold rating on GlaxoSmithKline. The company’s shares closed last Friday at p1881.50.
According to TipRanks.com, Parry is ranked #7055 out of 12284 analysts.
The word on The Street in general, suggests a Hold analyst consensus rating for GlaxoSmithKline with a p2082.36 average price target, which is an 8.5% upside from current levels. In a report issued on May 28, Bank of America Securities also maintained a Hold rating on the stock with a p2350.00 price target.
